Position
Chief Executive Officer
Company
VolitionRx
Description
On November 10, 2026, VolitionRx Limited CEO Cameron Reynolds entered into an agreement that temporarily reduces his annual base salary. The new agreement reflects a decrease from $355,456 to $236,970.50, aimed at supporting the company's cost reduction measures. This reduction will remain in effect until the Compensation Committee decides to reinstate his salary.
Quick answer
VolitionRx CEO Cameron Reynolds Accepts Temporary Salary Reduction (November 12, 2026). VolitionRx is based in Henderson, Nevada, United States.
- Who is the new Chief Executive Officer at VolitionRx?
- VolitionRx named Cameron Reynolds Chief Executive Officer, announced November 12, 2026.
- What did VolitionRx announce on November 12, 2026?
- On November 10, 2026, VolitionRx Limited CEO Cameron Reynolds entered into an agreement that temporarily reduces his annual base salary. The new agreement reflects a decrease from $355,456 to $236,970.50, aimed at supporting the company's cost reduction measures.
- What does VolitionRx do?
- VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment...
- Where is VolitionRx based?
- VolitionRx is based in Henderson, Nevada, United States.
- Which similar companies made leadership changes around the same time?
- Cerenome, Inc. (November 12, 2026), Change Agents Corporation. (November 5, 2026), Natera (November 5, 2026) and Crispr Therapeutics (November 3, 2026) also announced leadership changes within 45 days of VolitionRx.
Source: Fundz verified event record.
Other recent leadership changes in Genetics and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Cerenome, Inc. Appoints Ronald A. Andrews as Chief Business Officer (November 12, 2026)
- Change Agents Corporation Appoints Luisa Ingargiola as Principal Executive Officer (November 5, 2026)
- Natera Appoints Solomon Moshkevich as Chief Executive Officer (November 5, 2026)
- Crispr Therapeutics names Sivakesava Sakhamuri Chief Technical Officer (November 3, 2026)
- Genetix Biotherapeutics Appoints Meredith Manning as Chief Commercial Officer (October 19, 2026)
- ADLM Appoints Amanda R. Ragula as Chief Financial Officer (October 14, 2026)
Who to call at VolitionRx, and when
A new leader at VolitionRx brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day VolitionRx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VolitionRx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VolitionRx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VolitionRx changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
VolitionRx changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.